• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® DRYSEAL SHEATH; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® DRYSEAL SHEATH; INTRODUCER, CATHETER Back to Search Results
Catalog Number DSL1828J
Device Problems Occlusion Within Device (1423); Difficult to Advance (2920)
Patient Problem Tissue Damage (2104)
Event Date 01/06/2015
Event Type  Injury  
Event Description
On (b)(6), the patient underwent endovascular repair of an abdominal aortic aneurysm using gore® excluder® aaa endoprostheses.It was reported that the left iliac artery was circumferentially calcified and stenosed.The diameter of the iliac artery is reportedly unknown.Angioplasty was performed on the left external iliac artery prior to the insertion of the gore® dryseal sheath ((b)(4)).When the sheath was inserted, some resistance was felt around the bifurcation of the left iliac artery.However, the sheath was advanced to the intended position and the delivery catheter of the trunk ipsilateral leg component was inserted.As the catheter reached around the accessory renal artery, it could not advance further.The physician withdraw the delivery catheter, and angiography showed the abnormal calcification around the tip of the sheath which blocked the advancement of the delivery catheter.The physician suspected that it was a piece of the intima decorticated from the left iliac artery.An open abdominal surgery was performed whereby the damaged left iliac artery and the abdominal aorta were repaired with a surgical graft.The patient tolerated the procedure.It was reported that during the open repair, the damage to the left common iliac artery and the cylindrical intima from the artery were confirmed.
 
Manufacturer Narrative
Manufacturing evaluation performed.A review of the manufacturing records for the device verified that the lot met all pre-release specifications.According to the gore® dryseal sheath instructions for use (ifu), adequate vessel access is required to introduce the sheath into the vasculature.Careful evaluation of vessel size, anatomy, tortuosity, and disease state (including calcification, plaque, and thrombus) is required to ensure successful sheath introduction and subsequent withdrawal.If vessel is not adequate for access, major bleeding, vessel damage, or serious injury to the patient, including death, may result.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® DRYSEAL SHEATH
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL DEER VALLEY B/P
24416 n. 19th avenue
phoenix AZ 85085
Manufacturer Contact
kanae rikimaru
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key4472557
MDR Text Key5324730
Report Number3007284313-2015-00011
Device Sequence Number1
Product Code DYB
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K093791
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 01/06/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/02/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/31/2017
Device Catalogue NumberDSL1828J
Device Lot Number13064091
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/29/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age80 YR
-
-